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Hepatitis C virus (HCV) polyprotein translation depends on direct internal entry of the 40S ribosomal subunit mediated by
an internal ribosome entry segment (IRES) located in the 5 noncoding (5NC) region of the viral genome. HCV is genetically
heterogeneous and is characterized by the existence of a quasispecies distribution of the virus population within a single
infected individual. Cloning and sequencing strategies were used to characterize 5NC quasispecies genetically. Similar to
coding regions, the HCV 5NC region was distributed as a quasispecies, but it appeared to be subjected to stronger
conservatory constraints than other regions of the HCV genome, probably due to the need for structural (and functional)
conservation of the IRES. Indeed, most of the quasispecies substitutions were in unpaired regions of the IRES or clustered
such that base-pairing was maintained, whereas only 21% were expected to result in a loss of base-pairing. Quasispecies-
related structural changes could be predicted in the core cruciform of IRES domain III composed of the RNA helices which
extend from the four-way junction JIIIabc, mostly in minor variants, but sometimes in major ones. The results presented here
suggest the simultaneous presence in infected patients of a mixture of genetically distinct but closely related IRES
sequences that may have different structures. No significant genetic changes of 5NC quasispecies were observed after
interferon- treatment, except in patients with mixed genotype infection who cleared one of the infecting strains during
therapy, suggesting that the quasispecies distribution of IRES sequences does not play a role in HCV resistance toINTRODUCTION
Hepatitis C virus (HCV) is a single-strand RNA virus
belonging to the Flaviviridae family. Its positive-strand
RNA genome is about 10,000 nucleotides long and con-
tains a 5 noncoding (5NC) region, followed by a unique
open reading frame and a short 3 noncoding region
(Bukh et al., 1992; Grakoui et al., 1993). The mechanism
of HCV open reading frame translation initiation is differ-
ent from that of “classical” eukaryotic mRNAs, where the
eukaryotic initiation factor (eIF) 4F holoenzyme complex
ensures the recruitment of the 40S ribosomal subunit at
the capped 5 end of the mRNA (reviewed in Jackson and
Kaminski, 1995; Kean et al., 1999). Indeed, HCV belongs
to the group of positive-strand RNA viruses for which
ribosome recruitment depends on direct internal entry of
the 40S ribosomal subunit, independently of the mRNA 5
end, mediated by an “internal ribosome entry segment”
1 To whom correspondence and reprint requests should be ad-
dressed at Department of Bacteriology and Virology, Hoˆpital Henri
Mondor, 51 avenue du Mare´chal de Lattre de Tassigny, 94010©
A(IRES) carried on the mRNA (Tsukiyama-Kohara et al.,
1992). This exclusively IRES-dependent strategy of initi-
ation of protein synthesis has now been described for
many other positive-strand RNA viruses, such as all
picornaviruses, the pestiviruses, and the GB viruses
(GBV) from the Flaviviridae family (Borman et al., 1995;
Chon et al., 1998; Grace et al., 1999; Jubin et al., 2000; Le
et al., 1996).
Despite the genetic variability of HCV (Smith et al.,
1995), it has been possible to define a single predicted
RNA secondary structure for the IRES. This structure is
located between nucleotides 40 and 370 and contains
three stem-loops (II to IV) and a pseudoknot (Fig. 1)
(Honda et al., 1996, 1999a). The IRESs of all isolates of
HCV examined to date can be accommodated within this
same secondary structure, and short strictly conserved
primary sequence determinants can be identified (Smith
et al., 1995). This is reminiscent of observations pertain-
ing to other viruses which use this same strategy of
translation initiation, such as the picornaviruses (Jackson
et al., 1994), and bears witness to the constraints im-
posed on the IRES to maintain function. Nevertheless,interferon- therapy. In contrast, the overall quasispecies
participate in regulation of hepatic and extrahepatic HCV r
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of different genotypes or variant sequences demon-
strates different efficiencies (Collier et al., 1998; Honda et
al., 1999b; Laporte et al., 2000; Lerat et al., 2000).
HCV is genetically heterogeneous, like other RNA vi-
ruses, since the viral RNA polymerase is devoid of any
proofreading capacity. Nonlethal mutations that accumu-
late during viral replication are transmitted to progeny
virus and confer selective advantages or disadvantages
on them, depending on the replicative environment. The
continual apparition and selection of new mutations has
FIG. 1. Proposed secondary and tertiary RNA structures within the 5 noncoding region and the immediately downstream segment of the long open
reading frame of the prototype genotype 1b virus HCV-N (Hayashi et al., 1993; Honda et al., 1996, 1999a). Major structural domains are labeled I, II,
IIIa, IIIb, IIIc, IIId, IIIe, IIIf, and IV. The initiator AUG codon in stem-loop IV is highlighted. The circled nucleotides indicate differences between the
sequences of HCV-N and the prototype genotype 1a HCV-H virus (Inchauspe et al., 1991), which are clustered at four loci: UGA, GA, A1, and A2.
Reproduced from Honda et al. (1999b) with permission.
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two important consequences: (i) the selection of variant
strains during evolution in geographically or epidemio-
logically isolated populations, leading to the emergence
and progressive diversification of viral genotypes, includ-
ing six main clades and a large number of subtypes
(Robertson et al., 1998; Simmonds, 1999); and (ii) the
existence of a quasispecies distribution of the virus pop-
ulation within a single infected individual (Martell et al.,
1992; Weiner et al., 1991). In other terms, the virus
present in an infected subject at any given time is not a
homogeneous population corresponding to the infecting
virus, but rather a complex mixture of genetically related,
but distinct, viral subpopulations in an unstable equilibrium.
The quasispecies distribution of HCV plays a primor-
dial role in the physiopathology of infection, particularly
in viral persistence, cellular tropism and viral compart-
mentalization, and resistance to anti-viral treatment (re-
viewed in Pawlotsky, 2000a,b). To date, little is known
concerning the variation of the HCV IRES within the
quasispecies of infected individuals, at a given time or
over time, or the role that the IRES could be expected to
play in the progression of liver disease and the outcome
of antiviral treatment. The basis of treatment of chronic
hepatitis C is interferon- (IFN-), which is currently
used in combination with ribavirin, a molecule that po-
tentiates its antiviral effects (reviewed in Pawlotsky,
2000a). IFN- does not inhibit a specific viral enzymatic
function, but rather induces modifications of specific
immune responses, and the establishment of a nonspe-
cific antiviral state in infected cells by the activation of
numerous cellular genes. Thus, the inhibition of HCV
replication is a consequence, in part, of a global inhibi-
tion of translation in the infected cell. Therapeutic failure
is frequent. The outcome of antiviral treatment seems to
depend on many factors, among which virus-related pa-
rameters appear to play an important role (reviewed in
Pawlotsky, 2000a). These include the HCV genotype and
the level of both the viral replication and the genetic
complexity of the quasispecies population before the
start of treatment (Pawlotsky et al., 1998b; Toyoda et al.,
1997). The higher these last two parameters are, the less
the patient will respond to treatment. The most realistic
hypothesis is that the level of viral replication is linked to
the rate of mutation accumulation, and a high genetic
complexity is associated with an increased probability
that variants better adapted to the environmental condi-
tions created by IFN- will be present (Pawlotsky et al.,
1998b). Where patients do not eliminate the virus, IFN-
induces profound changes in the composition of the viral
quasispecies in various coding genomic regions, the
mechanisms of which depend on the pressure IFN-
exerts on the corresponding protein (Pawlotsky et al.,
1998a, 1999; Polyak et al., 1998). However, such selection
does not seem to favor intrinsically IFN--resistant vari-
ants, since retreatment of nonresponders to IFN- can
result in definitive viral clearance (Camma et al., 1999;
Pawlotsky et al., 1999). Overall, the mechanisms of HCV
resistance to IFN- are rather unusual, and it is not
unreasonable to propose that changes in translation
properties could intervene in response to the global
inhibition of translation. Effectively, viruses generally are
extremely adept at provoking differential translation and
frequently use the cellular machinery in unorthodox ways
or subvert entirely different cellular components to trans-
lational purposes (reviewed in Mathews, 1996).
We used cloning and sequencing strategies to gener-
ate a large number of 5NC sequences to assess
whether quasispecies distribution can be evidenced
within the HCV IRES sequence. IRES quasispecies evo-
lution was studied in vivo under strong environmental
pressures related to the administration of IFN-. Finally,
the relationship between IRES changes and HCV resis-
tance to IFN- therapy in vivo was analyzed.
RESULTS
HCV genotype determination
Six patients who did not achieve a sustained virolog-
ical response, i.e., who had detectable viral replication at
the end of treatment and at the end of posttreatment
follow-up, were randomly selected among 113 patients
with chronic hepatitis C treated with IFN- for the study
of the genetic heterogeneity of the 5NC region and its
evolution during and after therapy. The pretreatment se-
quences of the viruses infecting the six studied patients
in the region corresponding to NS5B were aligned with
reference sequences of the principal known HCV geno-
types, and phylogenetic analysis was performed by
means of the PHYLIP package (data not shown). Patients
1, 2, and 3 were found to be infected with HCV genotype
1b; patient 4 was found to be infected with HCV genotype
2a, and patients 5 and 6 were found to be infected with
HCV genotype 3a.
Quasispecies distribution of the 5NC region of HCV
As shown in Fig. 2, the patients were harboring mix-
tures of genetically distinct but closely related variants,
defining the quasispecies distribution of the 5NC region
of the HCV genome. The 5NC quasispecies were char-
acterized by the presence of both major variants, repre-
senting more than 10% of the quasispecies, and of minor
variants. As shown in Fig. 3, the pretreatment normalized
Shannon entropy of the 5NC region was high and of the
same order as that observed in other genomic regions
such as hypervariable region 1 (HVR1) of the E2 protein
or the central region of the NS5A gene (Pawlotsky et al.,
1998a, 1999). The mean pretreatment within-sample ge-
netic distances are shown in Fig. 4 and Table 1. Accord-
ing to the respective lengths of the analyzed genomic
fragments, the genetic distances described here ap-
peared to be smaller than those reported for the central
162 SOLER ET AL.
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region of the NS5A gene (Pawlotsky et al., 1998a) and
much smaller than those reported for HVR1 (Pawlotsky et
al., 1999). This suggests stronger conservatory pres-
sures bearing on the 5NC region than on other regions
of the genome analyzed to date.
Characteristics of observed 5NC substitutions
Altogether, as compared to the IRES sequences of
HCV prototype reference strains, 237 substitutions were
tabulated for the quasispecies variants found in the pre-
treatment samples. Each variant was scored compared
to its nearest prototype, rather than arbitrarily to the
global assigned genotype. When these substitutions
were positioned onto the predicted IRES secondary
structure (Honda et al., 1999a), 85 (36%) were found to lie
in unpaired regions of the IRES. This is in good agree-
ment with the fact that 32% of the sequences examined
correspond to unpaired residues. However, the impor-
tance of maintaining the secondary structure of the IRES
is evidenced by an examination of the 152 substitutions
located in paired regions of the IRES. One hundred two
of these clustered such that base-pairing was main-
tained, whereas only 50 mutations (21% of the total)
would be expected to result in a loss of base-pairing.
Generally, no significant site-specific clustering of the
mutations was evidenced, except for positions 104 and
107 in domain II and 204 in the apical loop of domain IIIb
where variants isolated from different patients carried
mutations. Notably, in the case of nucleotide 204 this
was unlinked to the genotype of the infecting virus.
Interestingly, the GGG triplet between nucleotides 266
and 268 of the hexanucleotide apical loop of stem loop
IIId was conserved in all of the observed sequences.
This triplet has been shown to be essential for IRES
activity both in vitro and in vivo in all of the HCV geno-
types as well as in the Flaviviruses, the Pestiviruses, and
GB virus B (Jubin et al., 2000). Overall, the nonrandom
distribution of the observed substitutions was incompat-
ible with artifacts related to errors made by the DNA
polymerase during the PCR reaction. Another situation
FIG. 3. Pretreatment (white) and posttreatment (black) normalized Shannon entropy of 5 noncoding quasispecies in the six patients selected for
this study. No significant changes were observed after treatment.
FIG. 4. Pretreatment (white) and posttreatment (black) average within-sample genetic distances of 5 noncoding quasispecies in the six patients.
No common evolutionary trend was observed after treatment.
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was seen in variants of patient 5: the IRESs appeared
chimeric, with successive blocks of sequence reminis-
cent of different genotypes. This may be suggestive of
multiple recombination events. However, it cannot for-
mally be ruled out that such sequences resulted from
reverse transcription or PCR artifacts, such as for in-
stance a change of template in midpolymerization, or
priming on one template with an unfinished product from
another template.
Genetic evolution of 5NC quasispecies after IFN-
therapy
As shown in Fig. 3, the genetic diversity of the 5NC
quasispecies, as measured by the Shannon entropy, did
not vary significantly after IFN- therapy, except in pa-
tient 4 in whom it was reduced approximately by one-
half. The within-sample genetic distances were different
after therapy compared to before treatment, especially in
patient 5 in whom it was reduced by two-thirds, but no
common trend toward an increase or decrease could be
detected for the group of six patients selected for this
study (Fig. 4). Table 1 shows the comparison between
mean between-sample genetic distances and mean
within-sample genetic distances in the six patients. No
significant difference was observed for patients 1, 2, 3, 5,
and 6, suggesting that no significant genetic evolution of
the 5NC quasispecies occurred during the follow-up
period. However, in patients 1, 2, 3, and 6, the variants
isolated after treatment generally had different se-
quences than the variants isolated pretreatment. This
appeared to be due to random sampling of different
variants constituting the same viral quasispecies, the
composition of which did not change significantly over
time. In contrast, the mean between-sample genetic dis-
tance was significantly higher than the mean within-
sample genetic distance in the case of patient 4, sug-
gesting a significant genetic change of the 5NC region
quasispecies during the follow-up period.
These findings were confirmed by phylogenetic anal-
ysis of the pre- and posttreatment 5NC quasispecies in
the six patients (Fig. 5). In patients 1, 2, 3, and 6, the
phylogenetic trees were characterized by interminglings
of the sequences isolated before and after treatment,
respectively. This finding was in keeping with a genetic
stasis of the quasispecies during the follow-up period. In
contrast, in patient 4, there was a distinctive clustering of
quasispecies sequences according to sampling time, a
finding in keeping with a significant change of the qua-
sispecies composition over time. Finally, in patient 5, the
phylogenetic tree showed interminglings of sequences
isolated at different time points and a trend toward clus-
tering. In both cases, a left-hand cluster and a right-hand
cluster could be differentiated (Fig. 5).
Upon close examination of the primary sequence data,
it became apparent that for patient 4, all the IRESs
located in the left-hand cluster of Fig. 5 (but none from
the right-hand cluster) resembled the IRES of a genotype
1b HCV rather than that of a genotype 2a virus. This
observation was based on the presence of a C residue at
nucleotide position 204 and the absence of other geno-
type 2a-specific residues. Similarly, for patient 5, the
IRESs found on the left-hand side of the phylogenetic
FIG. 5. Phylogenetic trees of 5 noncoding region quasispecies in the
six subjects studied before IFN- treatment and at the end of follow-up,
i.e., 6 months after IFN- withdrawal. The phylogenetic reconstructions
are neighbor-joining trees. Pretreatment sequences are represented by
filled circles and posttreatment sequences are represented by open
squares.
TABLE 1
Genetic Evolution of 5NC Quasispecies upon IFN- Treatment
Patient
Mean (SEM) genetic
distance within
pretreatment sample P
Mean (SEM) genetic
distance between
sample
1 0.0122 (0.0008) NS 0.0170 (0.0021)
2 0.0066 (0.0008) NS 0.0093 (0.0008)
3 0.0157 (0.0021) NS 0.0158 (0.0014)
4 0.0263 (0.0020) 0.0001 0.0377 (0.0021)
5 0.0432 (0.0019) NS 0.0394 (0.0014)
6 0.0075 (0.0004) NS 0.0073 (0.0003)
Note. NS, not significantly different.
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tree are suggestive of a genotype 1 virus rather than a
genotype 3a virus. In light of these observations, geno-
typing of the viruses present in all patients at the end of
the follow-up period was undertaken, by direct sequenc-
ing of the region corresponding to NS5B. This analysis
confirmed that the pre- and posttreatment genotypes
were the same in patients 1, 2, 3, and 6. In contrast, the
major pretreatment sequence was of genotype 2a and
genotype 3a in patients 4 and 5, respectively, whereas
the major posttreatment sequence was of genotype 1b in
both instances at the end of follow-up (data not shown).
The genetic and structural patterns in these two patients
could therefore be interpreted as follows: in patient 4
before treatment, both genotype 2a (right-hand cluster)
and 1b (left-hand cluster) sequences were present as a
result of mixed genotype infection, whereas only geno-
type 1b sequences were found at the end of follow-up as
a result of the selection by IFN- therapy of the most
resistant HCV genotype (Fig. 5). Similarly, in patient 5
before treatment, both genotype 3a (right-hand cluster)
and 1b (left-hand cluster) sequences were present as a
result of mixed genotype infection, whereas only geno-
type 1b sequences were found at the end of follow-up,
again as a result of the selection by IFN- therapy of the
most resistant HCV genotype (data not shown). Interest-
ingly, similar to in patients 1, 2, 3, and 6, genotype 1b
5NC sequences showed no significant genetic evolu-
tion during the study period in patients 4 and 5 (Fig. 5).
Putative impact of 5NC quasispecies heterogeneity
on IRES structure
We attempted to predict the potential effects of the
observed sequence variations on IRES secondary struc-
ture on the basis of thermodynamic considerations. To
this end, each individual variant sequence was analyzed
using the Zuker MFOLD program (Zuker, 1994), and the
three RNA structural domains which contact the 40S
ribosomal subunit (Spahn et al., 2001) were considered
independently. Table 2 typifies the global impact of se-
TABLE 2
MFOLD Analysis of Nucleotides 141–252 (the Domain III Core Cruciform) of the Different Sequences Determined before Treatment
% Quasispeciesa Stabilityb Fluidityc Predominant structural modificationsd
Patient 1 (genotype 1b) 93 42.5 to 39.2 1 None
3 45.0 (40.5; 2nd) 1 Single stem-loop
3 35.6 (34.9; 2nd) 3 Subdomains IIIc and IIIb-p fluid
Patient 2 (genotype 1b) 100 43.4 to 41.1 1 None
Patient 3 (genotype 1b) 93 41.1 1 None
3 38.5 2 2nd structure: single stem-loop
3 38.9 (36.9; 3rd) 2 Single stem-loop
Patient 4 (genotypes 2a  1b) 29 48.0 to 41.1 1 None
3 49.7 (46.0; 2nd) 1 Single stem-loop
67 50.1 to 46.6 2 2nd structure: single stem-loop
Patient 5 (genotypes 3a  1b) 30 41.1 to 38.8 1 None
56 48.6 to 41.1 2 2nd structure: single stem-loop
3 34.1 3 Misfolding of subdomains IIIc and IIIb-p
3 37.7 (34.7; 8th) 3 Subdomains IIIc and IIIb fluid
3 38.7 (37.1; 5th) 5 Subdomains IIIc and IIIb-p fluid
3 37.5 (35.8; 7th) 7 Subdomains IIIc and IIIb fluid
Patient 6 (genotype 3a) 3 40.1 (37.4; 4th) 1 Single stem-loop
3 45.4 (39.0; 4th) 2 Misfolding of subdomains IIIa, IIIc, IIIb-p
Single stem-loop
80 43.3 to 43.1
(43.1 to 42.9; 2nd)
3 Subdomains IIIa, IIIc, and IIIb-p fluid
7 42.5 to 42.4
(42.3 to 42.2; 2nd)
5 Subdomains IIIa, IIIc, and IIIb-p fluid
7 38.7 (37.9; 5th) 8 Subdomains IIIc and IIIb fluid
Prototype strains
Genotype 1b 41.1 1 None
Genotype 2a 44.9 (44.3; 2nd) 2 Misfolding of subdomains IIIc and IIIb
Genotype 3a 43.7 2 2nd structure: single stem-loop
a Values were rounded to the nearest whole number (30 clones total per patient).
b Minimal energy is given for the most stable structure in Kcal/mol. Where that is not the predicted cruciform, the stability of that structure and its
ranking are given in parentheses.
c Fluidity of the structure is scored as the number of alternative structures of minimal energies within 5% of the most stable.
d Subdomain IIIb was further subdivided into IIIb-a (corresponding to the apical part, above the lateral bulges) and IIIb-p (corresponding to the
proximal stem: nucleotides 172–181 paired to nucleotides 218–227) to accommodate differential disruptions within this subdomain.
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quence variation on predicted RNA secondary structure
and shows the results obtained for the core cruciform of
domain III composed of the RNA helices which extend
from the four-way JIIIabc junction. Compared to the pro-
totype reference sequences, an increase or decrease in
the stability of the expected cruciform was frequently
observed, e.g., for variants infecting patients 4 and 5,
respectively. An increase in the number of alternative
structures of similar stability (scored as fluidity) was
observed in the case of patients 5 and 6. This change
was particularly marked in certain cases where the ex-
pected cruciform came very low in the ranking, some-
times being well below 5% less stable than alternative
structures. Furthermore, for patient 5 the alternative
structures were often bush-like, rather than true alterna-
tive cruciforms (data not shown). The core cruciform of
domain III can often be proposed to adopt an alternative
structure, consisting of a single stem-loop (see HCV
genotype 3a reference strain, Table 2). Interestingly, this
structure was pushed to the forefront in minor variants
infecting patients 1, 3, 4, and 6, being over 5% more
stable than the expected cruciform.
Table 3 summarizes the MFOLD predicted RNA sec-
ondary structure data for each individual variant of the
posttreatment quasispecies populations. When these
data were compared to those of Table 2, no significant
differences were seen in the cases of patients 1, 2, 3, and
6. In contrast, for patient 4, the clustering of the quasi-
species sequences shown in Fig. 5 could be correlated
with definite differences of the predicted IRES structures
before and after treatment (Fig. 6). The stability of the
cruciform in all cases was at least 6% lower than that
seen in over 70% of the pretreatment quasispecies vari-
ants. Similarly, for patient 5 there was a distinct tendency
toward reduced fluidity of the cruciform posttreatment
correlating with the genotype-specific clustering of the
corresponding variants in the phylogenetic trees (data
not shown).
DISCUSSION
In the present study, 360 5NC sequences from pa-
tients infected with different HCV genotypes were gen-
erated to characterize the quasispecies distribution of
this region and its evolution in the context of profound
environmental changes, such as those induced by anti-
viral therapy. IFN- treatment has been shown previously
to induce profound HCV quasispecies changes in coding
genomic regions subjected to various pressures from
IFN--induced effectors (Pawlotsky et al., 1998a, 1999;
Polyak et al., 1998). Our results show that the 5NC
region of the HCV genome, similar to coding regions, has
TABLE 3
MFOLD Analysis of Nucleotides 141–252 (the Domain III Core Cruciform) of the Different Sequences Determined Post-Treatment
Patient % Quasispeciesa Stabilityb Fluidityc Predominant structural modificationsd
1 95 44.2 to 40.3 1 None
3 41.3 2 2nd structure: single stem-loop
2 95 41.1 1 None
3 39.2 2 2nd structure: single stem-loop
3 91 41.1 to 39.3 1 None
7 38.9 2 2nd structure: misfolding of subdomains IIIc and IIIb-p
4 95 43.8 to 41.1 1 None
3 34.0 3 Single stem-loop
Misfolding of subdomains IIIc and IIIb-p
5 77 41.1 to 39.9 1 None
6 38.1 to 37.6
(35.4 to 35.3; 2nd)
1 Single stem-loop
6 40.7 to 38.9 2 2nd structure: misfolding of subdomains IIIa, IIIc, and IIIb-p
3 41.5 (39.9; 2nd) 2 Misfolding of subdomains IIIc and IIIb
3 36.7 5 All subdomains fluid
6 3 43.3 (48.0; 3rd) 2 Misfolding of subdomains IIIa, IIIc, IIIb-p
Single stem-loop
70 43.3 (43.1; 2nd) 3 Subdomains IIIa, IIIc, IIIb-p fluid
3 44.8 (44.6; 2nd) 4 Subdomains IIIa, IIIc, IIIb-p fluid
7 45.1 (43.3; 3rd) 4 Subdomains IIIa, IIIc, IIIb-p fluid
17 40.7 (38.3; 5th) 6 All subdomains fluid
a Values were rounded to the nearest whole number (30 clones total per patient).
b Minimal energy is given for the most stable structure in Kcal/mol. Where that is not the predicted cruciform, the stability of that structure and its
ranking are given in parentheses.
c Fluidity of the structure is scored as the number of alternative structures of minimal energies within 5% of the most stable.
d Subdomain IIIb was further subdivided into IIIb-a (corresponding to the apical part, above the lateral bulges) and IIIb-p (corresponding to the
proximal stem: nucleotides 172–181 paired to nucleotides 218–227) to accommodate differential disruptions within this subdomain.
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a quasispecies distribution, characterized by the simul-
taneous presence at any time in each individual patient
of a mixture of genetically distinct but closely related
5NC sequences.
The Shannon entropy, an estimate of the size of the
5NC quasispecies sequence repertoire, was of the
same order as in other genomic regions (Pawlotsky et
al., 1998a, 1999; Sandres et al., 2000). Nevertheless, the
overall number of observed mutations and the average
within-sample genetic distances were smaller than in
the NS5A gene, a region highly variable at the nucleotide
level, but the protein sequence of which is subject to
conservatory constraints linked to NS5A protein struc-
ture and function (Pawlotsky et al., 1998a; Caste´ra, L.,
Soulier, A., Dhumeaux, D., and Pawlotsky, J. M.; Lopez-
Aguirre, Y., Frainais, P. O., McHutchison, J. G., Dhumeaux,
D., and Pawlotsky, J. M., unpublished observations). In
the 5NC, these parameters were also much smaller
than in HVR1, a region highly, but not absolutely (Penin et
al., 2001), tolerant to amino acid substitutions and sub-
ject to strong positive pressure toward change from both
the humoral and the cytotoxic immune responses of the
host (Weiner et al., 1991; Polyak et al., 1998; Pawlotsky et
al., 1999). Certain positions in the 5NC region were
refractory to quasispecies substitutions. This was partic-
ular in the case of the GGG triplet between nucleotides
266 and 268 that has recently been shown to be essen-
tial for maintaining IRES structure and activity, being
involved in the interaction with the 40S ribosomal subunit
(Jubin et al., 2000; Kolupaeva et al., 2000). Furthermore, a
majority of the mutations occurring in paired regions of
the RNA were such that base-pairing was maintained.
Overall, of the 237 substitutions observed in the patients
studied, only a minority (21%) would be expected to result
in a loss of base-pairing, i.e., an alteration of the IRES
structure. Finally, IFN- treatment did not induce signifi-
cant qualitative changes in 5NC quasispecies, except in
patients with a mixed infection who cleared one of the
infecting viruses during therapy. In these patients (pa-
tients 4 and 5), no dramatic 5NC changes were ob-
served in the persisting genotype quasispecies. Alto-
gether, our findings point to very strong conservatory
constraints on the HCV 5NC region RNA sequence,
apparently owing to the need for IRES structure and
function conservation. The accumulation of mutations
during replication is a random event depending on the
error rate of the viral RNA polymerase that probably
occurs in the 5NC region at the same rate as in other
regions of the HCV genome. It is thus probable that a
majority of mutations in this region are lethal and lead to
defective particles. In contrast, mutations compatible
with IRES function can be transmitted to progeny virus.
Whether or not such mutations may confer significant
survival advantages or disadvantages on the corre-
sponding virions remains to be established. It is note-
worthy, however, that in most cases, the major quasispe-
cies sequences were predicted to have no structural
modifications relative to the prototype reference se-
quence, suggesting that these variants could be best
adapted to most replicative environments.
In most of the patients, at the two time points studied,
several quasispecies sequences were predicted to re-
FIG. 6. Correlation between quasispecies phylogeny and IRES sec-
ondary structure in patient 4. The most stable predicted secondary
structures are shown for representative members of the quasispecies
population, as indicated, and the energy of the structure is given in
Kcal/mol. G–C pairs are represented by filled circles; A–U or G–U pairs
are represented by hatched spots, and unpaired residues are repre-
sented by open circles.
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sult in structural modifications in the core cruciform of
domain III composed of the RNA helices extending from
the four-way JIIIabc junction (Tables 2 and 3). This do-
main has been shown to comprise important determi-
nants of both eIF3 and 40S ribosomal subunit binding
affinity (Kieft et al., 2001). Various studies have shown
that the efficiency of HCV protein synthesis is very sen-
sitive to IRES sequence and structural changes. Effec-
tively, variations in the functional capacities of distinct
HCV IRESs have been evidenced (Collier et al., 1998;
Honda et al., 1999b; Laporte et al., 2000; Lerat et al.,
2000). In this context, it will be particularly interesting to
study the effects of the structural alterations of quasispe-
cies variants on translation efficiency, since these could
be expected to influence the binding affinity of eIF3
and/or the 40S ribosomal subunit to the IRES (Kieft et al.,
2001; Spahn et al., 2001). Furthermore, noncanonical
translation initiation factors seem to be required for HCV
IRES function, and correct secondary and tertiary RNA
folding has been shown to be necessary for the binding
of cellular factors to the HCV IRES (Odreman-Macchioli
et al., 2000).
Hepatitis C virus replication appears to be compart-
mentalized. It has indeed been shown that quasispecies
variants isolated from various body compartments, in-
cluding the liver, peripheral blood, lymphocyte subsets,
and dendritic cells, are genetically different although
related (Afonso et al., 1999; Cabot et al., 1997; Lerat et al.,
1998; Navas et al., 1998). Recent indirect arguments
suggest that cell tropism of quasispecies variants could
be related to the HVR1 sequence and its specific recog-
nition of cell surface molecules, perhaps glycosamino-
glycans (Penin et al., 2001). As far as productive replica-
tion in these cells is concerned, IRES sequences were
shown to be associated with differential translational
efficiencies in different cell types (Laporte et al., 2000;
Lerat et al., 2000; Saiz et al., 1999). This suggests that the
IRES structure probably plays a role in the ability of HCV
variants to replicate in certain cells in infected patients.
Cell-dependent functional differences might be related to
different interactions with cofactor proteins found in the
various cell types and could play an important role in the
regulation of hepatic and extrahepatic HCV replication.
Thus, the overall quasispecies distribution of HCV ge-
nomes may be crucial for allowing cell recognition, pen-
etration, and replication of HCV virions in various cell
types, and these cells could play an important role in the
persistence of infection and the physiopathology of HCV-
related diseases.
Interestingly, the genotype changes after therapy re-
vealed in the case of patients 4 and 5 by quasispecies
analysis were indicative of mixed infections that re-
mained undetected by simple genotyping techniques. In
fact, based on the presence of prototype-specific poly-
morphism in the cloned isolates, it can be estimated that
before treatment 26% of the viruses infecting patient 4
and 34% of those infecting patient 5 were genotype 1,
whereas the remaining viruses were genotypes 2a and
3a, respectively. The latter genotypes are known to be
more sensitive to IFN- treatment than genotype 1 (Mar-
tinot-Peignoux et al., 1995; McHutchison et al., 1998;
Poynard et al., 1998; Zeuzem et al., 2000), although the
reason for such a difference has not been elucidated.
Given that certain viral protein functions could at least
partly inhibit the action of certain IFN--induced antiviral
effectors in infected cells, genotype-related sequence
differences might be associated with different HCV qua-
sispecies fitnesses in the presence of IFN-. This could
account for the differences in sensitivity to therapy ob-
served among different HCV genotypes or isolates. The
nature of the viral protein(s) and genome or protein
function(s) involved in HCV resistance to IFN- therapy
remains purely speculative at the present time. The role
of NS5A protein has been suggested, because NS5A
gene expression was shown to be able to antagonize the
antiviral action of IFN- in transfected cells in vitro (Gale
et al., 1999; Polyak et al., 1999). Viral polyprotein inhibi-
tion of the Jak-Stat pathway, the main pathway respon-
sible for IFN- signal transduction, has also been re-
ported in vitro (Heim et al., 1999), but the involved mech-
anisms remain unknown. Overall, several genome or
viral protein functions, or both, and their interactions with
numerous host cell functions are probably involved in
HCV resistance to the nonspecific antiviral action of
IFN- in infected cells.
In patients who fail to clear HCV replication during
IFN- therapy, a change toward more efficient translation
might have been expected as a result of the global
inhibition of HCV protein translation by IFN-. The data
presented here do not support any role for the selection
of such “fitter” IRESs because our genetic analysis of
HCV 5NC quasispecies evolution showed no significant
qualitative changes in the patients who remained in-
fected with the same pretreatment HCV strain after ther-
apy. These results were reinforced by the fact that in
patients 4 and 5 genotype 1 virus subsets the 5NC
quasispecies after treatment remained genetically iden-
tical to the pretreatment ones in spite of strong pressure
toward change related to the administration of IFN-.
This apparent inability of IFN- to select fitter preexisting
HCV IRESs contrasts with its known ability to select fit
variants by exerting various pressures (including mostly
immune pressures and, possibly, direct interactions with
viral proteins) on coding genomic regions (Pawlotsky et
al., 1998a, 1999; Pawlotsky, 2000a; Polyak et al., 1998). It
might partly explain that IFN- is efficient in reducing
viral replication in a significant number of cases, whether
or not these patients are ultimately capable of eliminat-
ing infection. Overall, our results suggest that HCV re-
sistance to IFN- cannot be explained by the preexis-
tence and the selection of intrinsically IFN--resistant
IRESs, nor by IFN--induced modifications of 5NC qua-
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sispecies. Nevertheless, the role of genotype-related dif-
ferences in translational efficiency cannot be ruled out,
especially because peripheral blood viral load, which
best estimates viral production in the liver (Neumann et
al., 1998), is a strong predictor of the virological response
to IFN-.
MATERIALS AND METHODS
Materials
One hundred thirteen patients with chronic hepatitis C
(76 men, 37 women, mean age 46.2  13.9 years, range
18 to 74) eligible for antiviral treatment were included in
a clinical trial of IFN- therapy. The inclusion and exclu-
sion criteria have been described elsewhere (Pawlotsky
et al., 1996). All 113 patients were treated with 3
megaunits of IFN--2a (Roferon-A, Roche Products,
Basel, Switzerland) subcutaneously three times a week
for 6 months and were followed-up for a further 6 months
after IFN withdrawal. Among these patients, six who did
not achieve a sustained virological response, i.e., who
had detectable viral replication at the end of follow-up,
were randomly selected for the study of the genetic
heterogeneity of the 5NC region and its evolution during
and after therapy. There were four men and two women,
aged 32 to 64 years. Four of these patients had been
infected through blood transfusion, and one through in-
travenous drug use. The source of infection was un-
known in the remaining patient.
The HCV genotype of the viruses infecting these six
patients was determined by direct sequencing in the
nonstructural 5B region. The 5NC region was amplified
by PCR after reverse transcription before therapy and at
the end of follow-up. The amplified fragments were then
cloned and 30 clones per patient per time point were
sequenced. A total of 360 5NC clones were sequenced
and the genetic analysis of the corresponding quasispe-
cies was performed.
HCV RNA extraction and cDNA synthesis
RNA was extracted from 50 l serum with RNAzol
(RNA-B, Bioprobe Systems, Montreuil-sous-Bois, France)
and 45 l chloroform. Nucleic acids were precipitated
with isopropanol and washed with 70% ethanol. RNA
was reverse transcribed at 42°C for 60 min with 100 pmol
random hexamers (Pharmacia Biotech, Uppsala, Swe-
den) in the presence of 10 U avian myeloblastosis virus
(AMV) reverse transcriptase (Promega, Madison, WI).
HCV genotype determination
HCV genotype determination was performed by
means of PCR amplification and direct sequencing of the
NS5B region. Nested PCR was performed in a single
tube with 5 pmol each of external primers (sense:
5CCCTATGGGCTTCTCGTATGA3, nucleotide positions
7290 to 7310; antisense; 5GGGGCGGAGTACCTGGT-
CAT3, nucleotide positions 9062 to 9081) and 10 pmol
each of biotinylated internal primers (sense: 5TGGG-
GATCCCGTATGATACCCGCTGCTTTGA3, nucleotide po-
sitions 7320 to 7350; antisense: 5GGCGGAATTCCTGGT-
CATAGCCTCCGTGAA3, nucleotide positions 9035 to
9064). The two rounds of PCR were performed under the
same conditions, i.e., a 5-min denaturation at 94°C fol-
lowed by 30 cycles (94°C for 30 s, 45°C for 30 s, and
72°C for 45 s) and a final extension at 72°C for 5 min.
Amplified products were analyzed by electrophoresis
through a 3% NuSieve agarose gel (FMC, Rockland, ME)
and stained with ethidium bromide for visualization.
The NS5B PCR products were sequenced with the
AutoLoad Solid Phase Sequencing kit on an ALF Express
automated DNA sequencer (both from Pharmacia Bio-
tech). The sequencing primers were the Cy5-labeled
internal sense and antisense PCR primers. The genotype
was determined by means of phylogenetic analysis of
the generated sequences together with reference se-
quences of the principal genotypes from GenBank by
means of the PHYLIP package version 3.572 (provided by
J. Felsenstein, University of Washington, Seattle, WA).
PCR amplification of the 5NC region
One-round PCR was performed using 10 pmol of
sense (5CACCATGAATCACTCCCCTG3, nucleotide po-
sitions 28 to 47) and antisense (5GGTGCACGGTCTAC-
GAGACCT3, nucleotide positions 321 to 341) primers. A
5-min denaturation at 94°C was followed by 40 cycles
(94°C for 30 s, 55°C for 30 s, and 72°C for 30 s) and by
a final PCR extension at 72°C for 5 min. Amplified prod-
ucts were analyzed by electrophoresis through a 3%
NuSieve agarose gel (FMC) and stained with ethidium
bromide.
Cloning and sequencing of the 5NC region
PCR products were purified using the Sephaglas
BandPrep kit (Pharmacia Biotech) according to the man-
ufacturer’s protocol. Purified products were quantified by
ethidium bromide staining with DNA standards as con-
trols; 50 ng was directly ligated into 50 ng of the pTAg
vector (LigATor cloning kit, R&D Systems, Abingdon,
U.K.). Transformation of recombinant plasmid DNA into
Escherichia coli competent cells was performed accord-
ing to the manufacturer’s protocol and transformants
were grown on ampicillin-tetracycline plates. Cloned
DNA was reamplified by the same 5NC region PCR
procedure as that described above (except that the prim-
ers were biotinylated) and used for sequencing. Thirty
clones per sample were sequenced with the AutoLoad
Solid Phase Sequencing kit on the ALF Express auto-
mated DNA sequencer. The sequencing primers were
the Cy5-labeled sense and antisense PCR primers.
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Genetic characterization of 5NC quasispecies
We determined the entropy of 5NC quasispecies,
which is defined in terms of the probabilities of the
different sequences or clusters of sequences appearing
at a given time and measures the quasispecies reper-
toire size (Pawlotsky et al., 1998a, 1999). This measure is
calculated as S  ¥ i[ piln( pi)], where pi is the fre-
quency of each sequence in the viral quasispecies. Nor-
malized entropy Sn was calculated as Sn  S/ln30,
where 30 is the total number of sequences analyzed per
time point. Sn theoretically varies from 0 (no diversity) to
1 (maximum diversity).
Nucleotide sequences were aligned using the
CLUSTAL W program version 1.5 (Thompson et al., 1994).
Distances between pairs of sequences were calculated
by using the DNADIST module in the PHYLIP package.
Calculation was based on a Kimura two-parameter dis-
tance matrix with a transition-to-transversion ratio of 1.3.
The mean  standard error of the mean (SEM) within-
sample genetic distances were calculated at each time
point, as well as the mean  SEM between-sample
genetic distances on the basis of distances between
pairs of pretreatment (month 0)/posttreatment (month 12)
sequences. The PHYLIP program version 3.572 was
used to construct phylogenetic trees by means of the
neighbor-joining method (Felsenstein, 1995; Saitou and
Mei, 1987) with a sequence matrix determined by the
two-parameter method of Kimura. Trees were con-
structed for each patient.
Prediction of IRES structure
Each 5NC sequence was positioned manually onto
the consensus IRES secondary structure prediction of
Honda et al. (1999a), and quasispecies population vari-
ations were scored directly for whether unpaired regions
or paired residues were affected. In the latter case, each
individual sequence was assessed to determine if po-
tential base-pairing could be expected to be maintained
or lost. The eventual global impact of sequence variation
on predicted RNA secondary structure was determined
for each variant using the Zuker MFOLD program (Zuker,
1994). This program is based on thermodynamic consid-
erations, and the parameters used were energy differ-
ences of multiples of 5% from the minimal at 37°C. The
MFOLD program was found to be incapable of coher-
ently assessing the intact IRES structure. Thus, progres-
sive RNA synthesis was simulated. Global results are
typified by a consideration of the “core” cruciform struc-
ture of domain III of the IRES encompassing nucleotides
141 to 252, which folds around the four-way JIIIabc junc-
tion (Kieft et al., 2001).
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